Immunohistochemical distribution of advanced glycation end products (AGEs) in human osteoarthritic cartilage

Acta Histochemica

Volumn 113, Issue 6, 2011, Pages 613-618

  Hirose, Jun ^a   Yamabe, Soichiro ^b   Takada, Koji ^b   Okamoto, Nobukazu ^b   Nagai, Ryoji ^c   Mizuta, Hiroshi ^b  

^a KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c JAPAN WOMEN'S UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products (AGEs); Cartilage; Immunohistochemistry; Osteoarthritis; Receptor for AGEs (RAGE)

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; DIAMINO ACID; EPITOPE; N EPSILON (CARBOXYETHYL)LYSINE; PENTOSIDINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARTILAGE DEGENERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; OSTEOARTHRITIS; PATHOGENESIS; PROTEIN LOCALIZATION; PROTEIN MODIFICATION;

AGED; AGED, 80 AND OVER; CARTILAGE, ARTICULAR; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OSTEOARTHRITIS; RECEPTORS, IMMUNOLOGIC;

EID: 79957917510     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2010.06.007     Document Type: Article

References (47)

1. Bank R.A., Bayliss M.T., Lafeber F.P., Maroudas A., Tekoppele J.M. Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. The age-related increase in non-enzymatic glycation affects biomechanical properties of cartilage. Biochem J 1998, 330:345-351.
2. Bank R.A., Verzijl N., Lafeber F.P., Tekoppele J.M. Putative role of lysyl hydroxylation and pyridinoline cross-linking during adolescence in the occurrence of osteoarthritis at old age. Osteoarthritis Cartilage 2002, 10:127-134.
3. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405-412.
4. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005, 83:876-886.
5. Bowie A., O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000, 59:13-23.
6. Cecil D.L., Johnson K., Rediske J., Lotz M., Schmidt A.M., Terkeltaub R. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J Immunol 2005, 175:8296-8302.
7. Davies C.A., Herrick A.L., Cordingley L., Freemont A.J., Jeziorska M. Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis. Rheumatology 2009, 48:876-882.
8. DeGroot J., Verzijl N., Bank R.A., Lafeber F.P., Bijlsma J.W., TeKoppele J.M. Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation. Arthritis Rheum 1999, 42:1003-1009.
9. DeGroot J., Verzijl N., Wenting-van Wijk M.J., Jacobs K.M., Van El B., Van Roermund P.M., et al. Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum 2004, 50:1207-1215.
10. Felson D.T., Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum 1998, 41:1343-1355.
11. Fu M.X., Requena J.R., Jenkins A.J., Lyons T.J., Baynes J.W., et al. The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996, 271:9982-9986.
12. Gibson G.J., Verner J.J., Nelson F.R., Lin D.L. Degradation of the cartilage collagen matrix associated with changes in chondrocytes in osteoarthrosis. Assessment by loss of background fluorescence and immunodetection of matrix components. J Orthop Res 2001, 19:33-42.
13. Gibson J.S., Milner P.I., White R., Fairfax T.P., Wilkins R.J. Oxygen and reactive oxygen species in articular cartilage: modulators of ionic homeostasis. Pflugers Arch 2008, 455:563-573.
14. Hanford L.E., Enghild J.J., Valnickova Z., Petersen S.V., Schaefer L.M., et al. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J Biol Chem 2004, 279:50019-50024.
15. Henrotin Y.E., Bruckner P., Pujol J.P. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 2003, 11:747-755.
16. Hofmann M.A., Schiekofer S., Isermann B., Kanitz M., Henkels M., et al. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia 1999, 42:222-232.
17. Kato S., Horiuchi S., Liu J., Cleveland D.W., Shibata N., Nakashima K., et al. Advanced glycation endproduct-modified superoxide dismutase-1 (SOD1)-positive inclusions are common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutations and transgenic mice expressing human SOD1 with a G85R mutation. Acta Neuropathol 2000, 100:490-505.
18. Koito W., Araki T., Horiuchi S., Nagai R. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody. J Biochem 2004, 136:831-837.
19. Loeser R.F., Yammani R.R., Carlson C.S., Chen H., Cole A., Im H.J., et al. Articular chondrocytes express the receptor for advanced glycation end products: potential role in osteoarthritis. Arthritis Rheum 2005, 52:2376-2385.
20. McClelland R.A., Finlay P., Walker K.J., Nicholson D., Robertson J.F., Blamey R.W., et al. Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer. Cancer Res 1990, 50:3545-3550.
21. Mera K., Nagai M., Brock J.W., Fujiwara Y., Murata T., Maruyama T., et al. Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products. J Immunol Methods 2008, 334:82-90.
22. Nagai R., Ikeda K., Higashi T., Sano H., Jinnouchi Y., Araki T., et al. Hydroxyl radical mediates N epsilon-(carboxymethyl)lysine formation from Amadori product. Biochem Biophys Res Commun 1997, 234:167-172.
23. Nagai R., Unno Y., Hayashi M.C., Masuda S., Hayase F., Kinae N., et al. Peroxynitrite induces formation of N(epsilon)-(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite. Diabetes 2002, 51:2833-2839.
24. Nagai R., Hayashi C.M., Xia L., Takeya M., Horiuchi S. Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins. J Biol Chem 2002, 277:48905-48912.
25. Nagai R., Fujiwara Y., Mera K., Yamagata K., Sakashita N., Takeya M. Immunochemical detection of Nepsilon-(carboxyethyl)lysine using a specific antibody. J Immunol Methods 2008, 332:112-120.
26. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992, 267:14998-15004.
27. Nelson F., Dahlberg L., Laverty S., Reiner A., Pidoux I., Ionescu M., et al. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 1998, 102:2115-2125.
28. Phillips S.A., Thornalley P.J. The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur J Biochem 1993, 212:101-105.
29. Pokharna H.K., Pottenger L.A. Nonenzymatic glycation of cartilage proteoglycans: an in vivo and in vitro study. Glycoconj J 1997, 14:917-923.
30. Pritzker K.P., Gay S., Jimenez S.A., Ostergaard K., Pelletier J.P., Revell P.A., et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 2006, 14:13-29.
31. Ruiz-Romero C., Carreira V., Rego I., Remeseiro S., Lopez-Armada M.J., Blanco F.J. Proteomic analysis of human osteoarthritic chondrocytes reveals protein changes in stress and glycolysis. Proteomics 2008, 8:495-507.
32. Schwab W., Friess U., Hempel U., Schulze E., Makita Z., Kasper M., et al. Immunohistochemical demonstration of -(carboxymethyl)lysine protein adducts in normal and osteoarthritic cartilage. Histochem Cell Biol 2002, 117:541-546.
33. Sell D.R., Nagaraj R.H., Grandhee S.K., Odetti P., Lapolla A., Fogarty J., et al. Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia. Diabetes Metab Rev 1991, 7:239-251.
34. Steenvoorden M.M., Huizinga T.W., Verzijl N., Bank R.A., Ronday H.K., et al. Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum 2006, 54:253-263.
35. Steinbeck M.J., Nesti L.J., Sharkey P.F., Parvizi J. Myeloperoxidase and chlorinated peptides in osteoarthritis: potential biomarkers of the disease. J Orthop Res 2007, 25:1128-1135.
36. Takeuchi M., Yamagishi S. TAGE (toxic AGEs) hypothesis in various chronic diseases. Med Hypotheses 2004, 63:449-452.
37. Uchiyama A., Ohishi T., Takahashi M., Kushida K., Inoue T., Fujie M., et al. Fluorophores from aging human articular cartilage. J Biochem 1991, 110:714-718.
38. Ulrich P., Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001, 56:1-21.
39. Verzijl N., DeGroot J., Thorpe S.R., Bank R.A., Shaw J.N., Lyons T.J., et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 2000, 275:39027-39031.
40. Verzijl N., DeGroot J., Oldehinkel E., Bank R.A., Thorpe S.R., Baynes J.W., et al. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J 2000, 350(Pt 2):381-387.
41. Verzijl N., DeGroot J., Bank R.A., Bayliss M.T., Bijlsma J.W., Lafeber F.P., et al. Age-related accumulation of the advanced glycation endproduct pentosidine in human articular cartilage aggrecan: the use of pentosidine levels as a quantitative measure of protein turnover. Matrix Biol 2001, 20:409-417.
42. Verzijl N., DeGroot J., Ben Z.C., Brau-Benjamin O., Maroudas A., Bank R.A., et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum 2002, 46:114-123.
43. Wells-Knecht K.J., Zyzak D.V., Litchfield J.E., Thorpe S.R., Baynes J.W. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 1995, 34:3702-3709.
44. Wimsey S., Lien C.F., Sharma S., Brennan P.A., Roach H.I., Harper G.D., et al. Changes in immunolocalisation of beta-dystroglycan and specific degradative enzymes in the osteoarthritic synovium. Osteoarthritis Cartilage 2006, 14:1181-1188.
45. Yammani R.R., Carlson C.S., Bresnick A.R., Loeser R.F. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products. Arthritis Rheum 2006, 54:2901-2911.
46. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 1994, 269:9889-9897.
47. Yuan Z.Q., Feldman R.I., Sun M., Olashaw N.E., Coppola D., Sussman G.E., et al. Inhibition of JNK by cellular stress- and tumor necrosis factor alpha-induced AKT2 through activation of the NF kappa B pathway in human epithelial Cells. J Biol Chem 2002, 277:29973-29982.